The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.
about
Visual dysfunction in Parkinson's diseaseMeta-analysis of risk factors for Parkinson's disease dementiaThe Genetic Basis of Cognitive Impairment and Dementia in Parkinson's DiseaseDeep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness AnalysisPotential benefits of therapeutic use of β2-adrenergic receptor agonists in neuroprotection and Parkinsonμs diseaseRational pharmacological approaches for cognitive dysfunction and depression in Parkinson's diseaseIncreased risk of Parkinson disease in patients with carbon monoxide intoxication: a population-based cohort studyPrecompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's DiseaseParkinson Disease and Dementia.Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease.Mortality in levodopa-treated Parkinson's disease.Global, Yet Incomplete Overview of Cohort Studies in Parkinson's disease.Evaluation of mild cognitive impairment subtypes in Parkinson's disease.Tracking Parkinson's: Study Design and Baseline Patient Data.Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's diseaseThe relationships between mild cognitive impairment and phenotype in Parkinson's diseaseLongitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment.The spectrum of cognitive impairment in Lewy body diseasesGenetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD studyPremotor and nonmotor features of Parkinson's disease.Lewy body dementias.Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease.Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.Therapeutic development paths for cognitive impairment in Parkinson's disease: report of a regulatory roundtableParkinson's disease mild cognitive impairment: application and validation of the criteria.Longitudinal study of normal cognition in Parkinson disease.Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression ProfilesParkinson's disease dementia: a neural networks perspective.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's diseaseClinical and Epidemiological Factors Associated with Mortality in Parkinson's Disease in a Brazilian Cohort.COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progDevelopment and external validation of a prognostic model in newly diagnosed Parkinson disease.Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.The role of prefrontal cortex during postural control in Parkinsonian syndromes a functional near-infrared spectroscopy study.Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection.
P2860
Q26740467-C9830395-25A8-4E60-A20A-A5936B2BC88BQ26743404-DECF39A9-8AA9-4FC5-AA31-7EDFD2D96617Q26744716-042AA32F-44AA-4087-BA9F-A6F4F290B8EDQ26779605-CDB6BBE8-4836-41E7-8D70-DD1FC4B3264EQ27012822-DCCB118E-50E0-40D8-9645-8FB01F0FE330Q28084380-A2E20682-9C09-4EAB-AB21-2821645CCB83Q28390984-855C1D44-6177-4EAE-A71E-04E49107DB31Q28601965-5E6BB0EB-22B0-48F1-84DA-1FE6C455AE3EQ30248574-ED6E27AB-FF67-48F9-8478-60184FB75C9CQ30276531-EFE2C0BC-2BD1-4C1B-B16D-14492B459026Q30414368-42E1D432-6A2B-4FAE-8849-7D1EE07B16C2Q30491906-E6CC425E-FFC3-4158-B688-2750CD747D9CQ30577625-C4FA65D8-0237-49D3-9D3A-417A232242CEQ31008758-B3C21750-55B8-4784-9CA6-1BA5E34F9D15Q31097119-240759C5-4739-4628-B8C9-5498CED06D70Q33571889-459AC08A-6F4F-4EC9-BCA4-DC1FD21E64EBQ33788172-C6B3B88F-AA73-4E4C-94EF-D88E612DE96DQ33917203-8CABE85D-85F0-4848-8FAE-0B0171654B7AQ33965475-3C0E8266-3517-4F63-9D3A-F705CA106BCAQ34019751-68529539-95F1-4799-8ADB-71A395458798Q34174901-50FF2431-6974-44FB-8FC0-A88113DDFCECQ34274224-EEA7FC3D-9936-423F-9225-7D6E0571E67EQ34502646-AE4E6B10-5463-46E9-9BF1-3412B716E70BQ34974523-93B89CB7-E436-486B-BD1C-077CACDCC9F4Q35040454-760A9CF8-FB41-43F4-9768-93B8161C0696Q35158915-B904D0D2-9A19-44E9-90BC-BF67F0F118ADQ35211545-1AD9B04E-3184-4162-8CCA-A94CD26FF2DCQ35233945-19CD93F3-9010-4FD1-A8CB-BE1A689AC376Q35771313-88CCFDDA-3D55-4DA0-B7C9-D544BBF794C9Q36056735-66D36BB2-170E-4C44-BB98-0A921F694140Q36186763-7E891646-39E3-4A15-9E45-28890501F8B8Q36332532-408DCDC4-7FB9-4D38-A882-F2AA2EC36B63Q36343417-C66F883D-B6F3-4172-B9E8-E92420EFAB23Q36447155-E4CC2BCB-8CED-49B9-B19F-0916A178AB21Q36616565-F3E34674-CDAD-4548-92B1-DE13699AD225Q36706035-525EE2B0-3B9A-4538-B711-10BB788B762CQ36762203-C13B2B29-4C96-447D-9A0A-6494EA344B0CQ36879941-A96B5ADB-EEF2-4D03-9618-F21F44458CFEQ36925905-58C7268A-B4D4-4BF5-80D8-2C4AF077539CQ37054007-C2D2E70C-D347-43B6-9BD2-25F8C5C5ED30
P2860
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The CamPaIGN study of Parkinso ...... ident population-based cohort.
@en
The CamPaIGN study of Parkinso ...... ident population-based cohort.
@nl
type
label
The CamPaIGN study of Parkinso ...... ident population-based cohort.
@en
The CamPaIGN study of Parkinso ...... ident population-based cohort.
@nl
prefLabel
The CamPaIGN study of Parkinso ...... ident population-based cohort.
@en
The CamPaIGN study of Parkinso ...... ident population-based cohort.
@nl
P2093
P2860
P50
P356
P1476
The CamPaIGN study of Parkinso ...... ident population-based cohort.
@en
P2093
Caroline H Williams-Gray
Jonathan R Evans
Sarah L Mason
P2860
P304
P356
10.1136/JNNP-2013-305277
P407
P577
2013-06-18T00:00:00Z